Hennion & Walsh Asset Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$969K Sell
2,699
-295
-10% -$90.2K 0.03% 568
2026
Q1
$750K Sell
2,994
-2,268
-43% -$564K 0.03% 581
2025
Q4
$1.45M Sell
5,262
-222
-4% -$60.7K 0.05% 424
2025
Q3
$1.44M Sell
5,484
-22
-0.4% -$5.35K 0.05% 420
2025
Q2
$1.2M Buy
5,506
+480
+10% +$103K 0.05% 451
2025
Q1
$1.13M Buy
5,026
+1,117
+29% +$308K 0.05% 448
2024
Q4
$1.28M Buy
3,909
+580
+17% +$183K 0.06% 405
2024
Q3
$999K Buy
3,329
+1,659
+99% +$508K 0.05% 452
2024
Q2
$550K Buy
1,670
+664
+66% +$235K 0.03% 567
2024
Q1
$398K Buy
+1,006
New +$372K 0.02% 625
2022
Q2
Sell
-730
Closed -$300K 803
2022
Q1
$300K Sell
730
-7
-0.9% -$2.74K 0.02% 656
2021
Q4
$346K Sell
737
-13
-2% -$5.6K 0.02% 619
2021
Q3
$318K Sell
750
-3
-0.4% -$1.26K 0.02% 623
2021
Q2
$270K Sell
753
-15
-2% -$4.96K 0.01% 643
2021
Q1
$216K Buy
+768
New +$220K 0.01% 658

Other funds holding WST